Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
China Isotope & Radiation Corp. ( (HK:1763) ) has issued an update.
China Isotope & Radiation Corporation has announced an upcoming board meeting scheduled for March 28, 2025, to review and approve the annual financial results for 2024 and discuss the potential recommendation of a final dividend. This meeting is significant as it will provide insights into the company’s financial health and strategic decisions, potentially impacting stakeholders and the company’s market positioning.
More about China Isotope & Radiation Corp.
China Isotope & Radiation Corporation operates in the nuclear technology industry, focusing on the production and distribution of isotopes and radiation-based products and services. The company is positioned in the market to serve various sectors, including medical, industrial, and scientific applications.
YTD Price Performance: 23.39%
Average Trading Volume: 159,192
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$4.06B
See more data about 1763 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue